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Abstract
To provide experimental evidence for the topology of the Naq–Ca2q exchanger protein NCX1 in the membrane, indirect
immunofluorescence studies using site specific anti-peptide antibodies and Flag-epitope insertion into chosen locations of
the protein were carried out. Anti-peptide antibodies AbO-6 and AbO-8 were raised against peptide segments present in a
large hydrophilic loop of about 500 amino acids, which separates the hydrophobic amino terminal part of the protein from
the hydrophobic carboxy terminal. AbO-10 was raised against the C-terminal tail of the protein. All three antibodies bound
to the exchanger protein expressed in transfected cells, in rat brain synaptic plasma membrane and in dog sarcolemmal
preparations. The antibodies bound only to those NCX1 isoforms that contained the epitope against which they were raised.
Detection of the exchanger protein in transfected cells in situ required the addition of permeabilizing agents suggesting an
intracellular location of the epitopes to which AbO-6, AbO-8 and AbO-10 bind. The Flag epitope was inserted into ten
putative extramembraneous segments along the exchanger protein. For topology studies, only the Flag-mutants that retained
Naq–Ca2q exchange activity in whole HeLa cells, were used. Immunofluorescence studies indicated, that the N-terminal of
the protein is extracellular, the first hydrophilic loop separating transmembrane helices 1 and 2 as well as the C-terminal,
are intracellular. q 1998 Elsevier Science B.V.
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1. Introduction
The Naq–Ca2q exchanger is involved in the regu-
w 2qxlation of the intracellular Ca in all excitable and
w xin many non-excitable cells 1 . It is encoded by at
w x w xleast three different genes NCX1 2 , NCX2 3 and
w x  q 2q q.NCX3 4 . In addition, an NCKX Na rCa qK
w xtransporter 5 is expressed in rod outer segment and
w xprobably also in the brain 6,7 .
Elucidation of the topology of membrane proteins
is important for understanding the structural basis of
) Corresponding author. Fax: q972-2-6757379; E-mail:
hannah@cc.huji.ac.il
their mechanism of action. Cloning of the Naq–Ca2q
exchanger genes and deduction of their primary struc-
w xtures followed by hydropathy analysis 8 suggested,
that their putative topology is similar. Based on
hydropathy analysis and using a window of 20–21
amino acids, the proteins of the cloned exchangers
 .could be organized into 12 transmembrane TM
w xhelices 2–5 . The 6 TM helices at the amino termi-
nal side are separated by a very large hydrophilic
loop from the 6 TM helices at the carboxy terminal
side.
Microsequencing of the N-terminal amino acid
segment of the purified bovine exchanger NCX1
indicated, that the first amino acid of the protein
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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corresponds to amino acid number 33 of the cloned
w xgene 9 . Based on this and on the presence of a
consensus signal peptidase cleavage site it has been
suggested, that the first putative TM helix is a cleav-
w xable signal peptide 9 .
An 11 TM helical model of the Naq–Ca2q ex-
changer predicts that the N- and C-terminal ends of
the protein face opposing sides of the membrane. The
extracellular location of the amino terminal, is sug-
gested by the location of the signal peptidase cleav-
w xage site 9 and by the presence of a glycosylation
w xsite at N9 10 . The intracellular location of the large
hydrophilic loop is supported by the presence of
consensus internal Ca2q and calmodulin binding sites
w x w x2,11 and phosphorylation sites 12 . Selective bind-
w3 xing of H labeled monoclonal antibodies to cell
homogenates and not to intact monolayer cultures of
cardiomyocytes, provided experimental evidence for
the intracellular location of the carboxy terminal part
w xof this loop 13 .
Recently, locations of transmembrane helices were
successfully predicted with a method based on the
w xneural network system 14–16 . This approach re-
sulted in 95% accuracy in predicting secondary struc-
ture and topology of integral membrane proteins.
Topological analysis of the rat brain Naq–Ca2q ex-
changer carried out by the network algorithm, pre-
dicted a different topological model than that derived
w xfrom hydropathy analysis 8 . The major difference
 .between the two models see Fig. 1 is in the number
of transmembrane helices and location of the N- and
C-terminals. In this paper, we are describing studies
designed to test directly the putative topological mod-
els of the Naq–Ca2q exchanger in situ. Immunocyto-
chemical localization using site specific antibodies
and epitope tagging was used.
2. Materials and methods
2.1. Site directed mutagenesis
The FLAG epitope tag, DYKDDDDK Eastman
. qKodak, New Haven, CT , was introduced into Na –
2q w xCa exchanger encoded by the rat brain rbe-2 17
w xgene using site directed mutagenesis 18 . The anti-
sense primers were 54–60 bases long. They con-
tained 24 bases corresponding to the Flag epitope and
q 2q  .Fig. 1. The topological models of the Na –Ca exchanger: A
The topological model of the rat brain exchanger RBE-2, result-
ing from hydropathy analysis using a window of 20 amino acids.
The extracellular orientation of the N-terminal is predicted by the
cleavage of the initial 32 amino acids that constitute the putative
w x  .signal peptide 9 . B The best topological model of the rat brain
exchanger RBE-2 predicted by the neural network program PHD
w x16 . The second best model predicted by the PHD program is an
8 TM helical model in which the stretch of amino acids between
 .C780 and G797 TMS 6 of the 9 TM helical model is part of the
extracellular loop. Consequently the C-terminal is predicted to be
intracellular.
15–18 bases corresponding to the sequence of rbe-2,
3X and 5X of the insertion point. Whenever possible, a
new HindIII restriction site was introduced for select-
ing mutants. In order to create this site, amino acids
valine or isoleucine, following the lysine of the
FLAG, were replaced by leucine details are shown
.in Fig. 7 . To ensure that no other mutation beyond
the planned occurred, fragments of 300–600 bases
containing the desired mutation were subcloned into
the corresponding sites of a wild type rbe-2. Plasmid
preparation was carried out by Wizard plasmid prepa-
 .ration kit Promega, Madison, WI . Sequencing was
w xcarried out by the dideoxy method 19 , using the
 . Sequenase II kit Amersham, UK . FC mutant see
.Fig. 7 was constructed by ligating HindIII–StuI
fragment which contains rbe-2 lacking its last eight
amino acids into pFLAG-CTS obtained gratefully
.from Dr. Robert Ferrari, Eastman Kodak upstream
and in-frame to the FLAG sequence. The clone was
excised and inserted into the expression vector pET
downstream to T7 promoter, resulting in rbe-2 gene
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in which the last eight amino acids were replaced
with the Flag sequence.
2.2. Expression of Naq–Ca2q exchanger clones in
HeLa-cells
Transient expression of the cloned rat brain or
heart exchanger genes rbe-1, rbe-2, rhe-1 and the
epitope-tagged rbe-2 in HeLa-cells, was done essen-
w xtially as described 17,20 . Briefly, 60–80% confluent
HeLa-cells were infected with the recombinant vac-
w xcinia virus VTF-7 21 and transfected with plasmid
DNA using DOTAP Boehringer-Mannheim, Ger-
. q 2qmany . Na –Ca exchange activity was examined
16–18 h post transfection, either in whole cells or in
reconstituted membranes, as previously described
w x17,20 .
2.3. Preparation of nati˝e membrane fractions
Rat brain synaptic plasma membranes were pre-
w xpared as described 22 . Canine heart sarcolemmal
w xmembranes were prepared as described 23,24 .
2.4. Preparation of anti-peptides antibodies
Peptides corresponding to chosen hydrophilic seg-
 .ments in RBE-2 Fig. 2 were custom-synthesized
and coupled to three different carrier proteins: Bovine
 .serum albumin BSA , Keyhole limpet hemocyanine
 . w xKLH and Thyroglobulin using glutaraldehyde 25 .
Primary immunizations of rabbits was done in a
solution of the coupled peptide with complete Fre-
 .und’s adjuvant Sigma, Israel . The booster injections
were done in incomplete adjuvant, at intervals of 4
weeks. In every second injection a different carrier
was used. Rabbits were routinely bled 7–10 days
after a given boost, starting after the second one.
Immunoreactivity of the sera was determined by en-
 .zyme-linked immunosorbent assay ELISA as de-
w xscribed 25 . Microtiter plates were coated with the
appropriate peptide antigen and incubated with serum
 2 5.diluted 10 –10 . Antibody binding was detected by
secondary anti-rabbit antibody conjugated to alkaline
phosphatase which catalyzed a colorimetric reaction.
Partial purification of the antisera was done by pread-
w xsorption on HeLa cells 26 .
 .Fig. 2. The preparation of anti-peptide antibodies. A Schematic
presentation of the Naq–Ca2q exchanger protein based on the
hydropathy plot. Dark boxes represent the putative transmem-
 .brane helices numbered from 1 to 11 and the dark line repre-
sents the hydrophilic segments of the protein connecting the TM
domains. The location of the sequences chosen for antibody
production is marked by arrows. The name of each peptide starts
with its first amino acid followed by its number in the linear
sequence of the mature protein after the cleavage of the signal
.peptide . The name of the corresponding antibody is also listed.
 .B Antibody binding to the corresponding peptide tested by
ELISA. Dotted columns represent the binding of the preimmune
sera and stripped columns represent the antisera. Each well
contained 500 ng of the appropriate peptide and the sera were
diluted 1:104.
2.5. Immunoblotting
For Western-blot analysis of the Naq–Ca2q ex-
changer, proteins from HeLa cells expressing the
exchanger genes, or membranes from rat brain or dog
heart were used. The protein extracts were boiled 5
min with Leammli sample buffer and were analyzed
w xby 7% SDS-PAGE 27 . Transfer to nitrocellulose,
 .treatment with blocking solution 3% BSA in PBS
and incubation with an appropriate dilution of pri-
mary antibody purified sera diluted in blocking solu-
. w x 125tion , was done by standard protocols 25 . I-Pro-
tein A was used to detect antigen–antibody com-
plexes.
2.6. Immunoprecipitation
 .Post transfection 14 h cells grown in 12-well
 .plates with methionine Met -free medium for 30
( )O. Cook et al.rBiochimica et Biophysica Acta 1371 1998 40–52 43
35 min, were washed and labeled with S-Met 25
.mCirml in Met-free medium for 2 h. The labeled
medium was removed, the cells were washed and
incubated with unlabeled methionine containing
medium for 1 h. Cells were lysed by RIPA 150 mM
NaCl, 100 mM Tris-HCl pH 8, 1 mM EDTA, 0.5%
.deoxycholate, 1% Triton X-100 and the lysate de-
rived from each well was incubated overnight at 48C
with 10 ml antiserum bound to 10 mg protein A-Sep-
harose beads. The beads were washed four times with
RIPA, once with high salt solution 100 mM NaCl,
.20 mM Tris-HCl pH-8, 1 mM EDTA after which the
proteins were eluted by boiling with Leammli sample
buffer and analyzed by SDS-PAGE.
2.7. Indirect immunofluorescence
HeLa cells grown on polylysine coated coverslips
 4 .4=10 cells , were infected and transfected as de-
 .scribed. Post transfection 18 h cells were washed
twice with PBS and fixed with 4% paraformaldehyde.
For permeabilization, cells were incubated for 5 min
in 0.25% Triton X-100 or Tween-20, Nonidate P-40
or, Digitonin. Permeabilized and non-permeabilized
cells were incubated with an appropriate dilution of
the primary antibody in PBS containing 10% new-
 ..born calf serum NCS for 3 h at 258C or overnight
at 48C. To detect the FLAG epitope, the anti-FLAG
 .  .monoclonal antibodies mAb Kodak IBI were used.
Depending on the primary antibody, Fluorescein iso-
 .thiocyanate FITC -conjugated goat anti rabbit or anti
mouse Jackson ImmunoResearch Laboratories, West
.Grove, PA secondary antibodies were used. These
antibodies were partially purified by preadsorption on
w xHeLa cells 26 , and diluted 1:1000 in PBS contain-
ing 10% NCS. Immunofluorescence microscopy was
performed using epifluorescence optics Zeiss Axio-
.scop .
2.8. Secondary structure analysis
Secondary structure analysis was derived from the
w xhydropathy analysis of Kyte and Doolittle 8 over a
window of 20 amino acids using the Genetics Com-
 .puter Group GCG, Madison, WI software and by
the PHD Profile fed neural network systems from
w xHeiDelberg 14–16 with the generous help of Dr.
Burkhard Rost from EMBL Heidelberg.
3. Results
3.1. Putati˝e topology of the Naq–Ca2q exchanger
Fig. 1 shows the putative topological models of the
Naq–Ca2q exchanger. In the model shown in Fig.
1A, the length of transmembrane helices is based on
hydropathy analysis over a window of 20 amino
w xacids 20 . The extracellular orientation of the N-
terminal relative to the plasma membrane is based on
w xthe location of the signal peptidase cleavage site 9
w xand the glycosylation site at N9 10 . The model
shown in Fig. 1B is the best model predicted by the
 .network system see Section 2 . The network system
does not identify the amino acid segments corre-
 .sponding to transmembrane segment TMS 2 and
TMS 6 of the hydropathy analysis based model Fig.
.1A as helical transmembrane segments. Hence, the
total number of TM helices decreases to 9. This
model also predicts, that the orientation of the N-
terminal is intracellular and that of the C-terminal is
extracellular. The network system also predicts a
 .‘second best model’ not shown in which the protein
is organized in 8 TM helices. In that model, the
stretch of amino acids between 780 and 797 TMS 6
.of Fig. 1B is predicted to be an extramembraneous
loop, since the probability of its assignment as a
 .helical transmembrane region HTM is similar to its
assignment as a non-HTM region. The 8 TM helical
model predicts that both the N- and C-terminals are
intracellular. To determine the membrane topology of
the protein, immunocytochemical analysis was car-
ried out.
3.2. Preparation and characterization of site specific
antibodies against the Naq–Ca2q exchanger
Based on the amino acid sequence of the cloned
q 2q w xrat Na –Ca exchanger gene 17,20 , extramembra-
neous segments of high immunogenecity were cho-
sen, corresponding peptides were synthesized and
used to immunize rabbits. Fig. 2A shows the location
of the sequences chosen for antibody production on a
schematic presentation of the Naq–Ca2q exchanger
w xbased on the original topological model 2 . Peptides
G341, R620 and D636, are localized within the large
hydrophilic loop of the exchanger protein, which is
cytoplasmic in all three putative models. Q74 is
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within the first hydrophilic loop separating TMS 1
and TMS 2. G876 is localized within the hydrophilic
 .segment separating TMS 10 and TMS 11 Fig. 1A or
 .TMS 8 and 9 Fig. 1B or TMS 7 and 8 of the second
 .best model of the network system not shown . Pep-
tide S915 corresponds to the C-terminal extramem-
braneous tail of the Naq–Ca2q exchanger. Antibody
production was tested by ELISA using the respective
 .immunizing peptides as the antigen Fig. 2B . The
sera of all the immunized rabbits, contained antibod-
ies against the appropriate peptide antigen. Their
affinity to the immunizing peptides, determined at
dilutions between 10y2–10y5, was similar.
To find out whether these antibodies recognize the
Naq–Ca2q exchanger protein, extracts from RBE-2
expressing HeLa cells were examined by Western
analysis. Three of the antibodies, AbO-6, AbO-8 and
AbO-10 that were prepared against peptides R620,
 .D636 and S915 respectively see Fig. 2 , bound in a
specific manner to a protein of about 130 kDa Fig.
.3 , which fits the calculated molecular mass of the
glycosylated Naq–Ca2q exchanger. The specific im-
munoreactive band was present only when the cells
 .were transfected with rbe-2 Fig. 3, lanes 4, 8, 12 ,
and not when the cells were transfected with the
plasmid vector pBluescript KS Fig. 3, lanes 3, 7,
.11 . No protein bands were detected, when the appro-
priate preimmune sera were used Fig. 3, lanes 1, 2,
.5, 6, 9, 10 . Although antibodies AbO-2, AbO-3 and
AbO-5 recognized in a similar manner to AbO-6,
AbO-8 and AbO-10 the antigenic peptides against
which they were raised, they did not bind to the
exchanger protein. They failed to reveal the ex-
changer protein by ELISA or Western analysis, they
did not immunoprecipitate the protein from trans-
fected cells nor did they bind to the proteins in situ,
as tested by immunofluorescence.
In order to confirm that the antibodies recognize
also the exchanger protein present in excitable mem-
brane preparations, we tested their ability to bind to
proteins derived from brain and heart membranes,
exhibiting Naq–Ca2q exchange activity. In Fig. 4,
we compare by Western analysis the binding of the
 .  .anti-peptide antibodies AbO-6 A , AbO-8 B and
 . q 2qAbO-10 C to the Na –Ca exchanger present in
native membranes. In sarcolemmal membranes and in
synaptic membranes the anti-peptide antibodies bind
to proteins of about 140 kDa. This band appeared in
native membranes, only when serum from immunized
rabbits was used. No specific bands were visible
when preimmune sera were used. For comparison,
the binding of all the three anti-peptide antibodies to
 .rbe-2 transfected cell extracts is also shown Fig. 4 .
The three rat isoforms of the Naq–Ca2q exchanger
gene NCX1 are identical, except in a segment of
amino acids within the large hydrophilic loop of the
w xprotein 17,20 . AbO-8 and AbO-10 were raised
against conserved peptide segments, present in all
three rat isoforms. AbO-6 was raised against a pep-
tide segment which is present in RHE-1 and RBE-2,
but missing in RBE-1. The ability of the anti-peptide
antibodies to distinguish between the different Naq–
Ca2q exchanger isoforms was tested by immuno-
precipitation of the exchanger protein from HeLa
cells transfected with each one of the three isoforms
 .Fig. 5A . Antibodies AbO-8 and AbO-10 immuno-
precipitated proteins of about 130 kDa molecular
mass from HeLa cells transfected with each one of
the three isoforms. AbO-6 however, immunoprecipi-
tated proteins only, when the transfection of the cells
q 2q  .Fig. 3. Binding of the anti-peptide antibodies to the Na –Ca exchanger protein expressed in HeLa cells. Proteins 100 mg in each lane
from rbe-2 and from mock transfected HeLa cells extract were analyzed by Western blot. pBluescript-KS transfected cells: Lanes 1, 3, 5,
7, 9, 11; rbe-2 transfected cells: lanes 2, 4, 6, 8, 10, 12. Proteins in lanes: 1, 2, 5, 6, 9, 10 were treated with preimmune sera; in lanes 3, 4
with AbO-6; in lanes 7, 8 with AbO-8; and in lanes 11, 12 with AbO-10. All sera were diluted 1:500. Antibody–antigen complexes were
detected by 125I-protein A.
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Fig. 4. Binding of the anti-peptide antibodies to rat brain synaptic
plasma membranes and dog sarcolemma. Western-blot analysis
was carried out with membrane proteins derived from rat brain
synaptosomes and dog heart sarcolemma using antibodies AbO-6,
AbO-8 and AbO-10. Binding of these antibodies to HeLa cells
 . transfected with rbe-2 positive control and with KS negative
.  .control was tested as well. A Binding of AbO-6 to rat brain
 .synaptic membrane proteins lane 1 , to cardiac sarcolemmal
 .membrane proteins lane 2 , and to proteins from HeLa cells
 .  .transfected with pBluescript KS lane 3 and rbe-2 lane 4 . In
lanes 5 and 6 the binding of the corresponding preimmune serum
to rat brain membranes and to sarcolemmal membranes respec-
 .tively is shown. B Binding of AbO-8 to brain membrane
 .  .proteins lane 4 , heart proteins lane 3 , and proteins from
 .pBluescript KS transfected cells lane 6 and rbe-2 transfected
 .cells lane 5 . Binding of the preimmune serum to brain mem-
 .  .brane proteins lane 2 and to heart proteins lane 1 is also
 . shown. C Binding of AbO-10 to brain membrane proteins lane
.  .1 , heart proteins lane 2 , and proteins from pBluescript KS
 .  .transfected cells lane 3 and rbe-2 transfected cells 4 . The
binding of the corresponding preimmune serum to brain mem-
 .  .brane proteins lane 5 and to heart proteins lane 6 is shown as
well. In each lane, 50 mg of protein was layered and the sera
were diluted 1:1000. 125I-protein A was used for detection of the
antibody–antigen complexes.
was carried out with rhe-1 or with rbe-2, but not
with rbe-1, as expected. AbO-6 and AbO-8 did not
immunoprecipitate any proteins from mock trans-
 .fected with the plasmid vector pBluescript KS HeLa
cell extracts. The 95 kDa band, which is revealed
when AbO-10 was used is present also when serum
from this rabbit prior to immunization was used not
.shown . This HeLa cell related protein, recognized by
the non-immunized rabbit, is not detected in any of
the native membrane preparations. Fig. 5B shows the
Naq gradient dependent Ca2q uptake activity ex-
pressed in whole HeLa cells, transfected with the
three Naq–Ca2q exchanger isoforms. No transport
activity is detected in mock transfected HeLa cells.
3.3. Topological studies of the Naq–Ca2q exchanger
using the anti-peptide antibodies
Location of the epitope recognized by the anti-
peptide antibodies relative to the plasma membrane,
was tested, by indirect immunofluorescence see Sec-
.tion 2 . Fig. 6 shows an experiment, in which HeLa
cells were transfected with rbe-2 and exposed to the
three anti-peptide antibodies, AbO-6, AbO-8 and
 .Fig. 5. The isoform specificity of the anti-peptide antibodies. A
HeLa cells transfected with the three rat exchanger isoforms and
mock transfected with the vector were metabolically labeled with
35S-Methionine, immunoprecipitated and analyzed by SDS-PAGE
as described in Section 2. Transfection with pBluescript KS:
lanes 1, 5, 9; with rhe-1: lanes 2, 6, 10; with rbe-1: lanes 3, 7,
11; and with rbe-2: lanes 4, 8, 12. Antibodies used for immuno-
precipitation: AbO-6: lanes 1, 2, 3, 4; AbO-8: lanes 5, 6, 7, 8;
 . 2q AbO-10: lanes 9, 10, 11, 12. B Ca uptake with dotted
.  . qcolumns and without stripped columns Na gradient, by HeLa
cells transfected with the three rat exchanger isoforms: rhe-1,
rbe-1, rbe-2, and mock transfected with the vector KS.
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AbO-10. Exposure of the cells to the antibodies in the
absence of permeabilizing agents Fig. 6, left side
.panel did not reveal a fluorescent signal with any
one of the antibodies, above the background. Phase
microscopy showed, that this background fluores-
cence was associated with broken cells only. In 10
different experiments it did not exceed 2% of the
total number of cells. Permeabilization of the trans-
Fig. 6. The immunofluorescent labeling of RBE-2 expressed in
HeLa cells. Transfection and treatment of the cells was carried
out as described in Section 2. The right side panel shows labeling
of cells permeabilized with Triton X-100 and the left side panel
shows the labeling of non-permeabilized cells. Bound antibodies
were detected with FITC- conjugated goat anti-rabbit antibodies.
 .In A and B the control mock transfected cells with pBluescript
are shown. The following anti-peptide antibodies were used:
AbO-10: A, B, G, H; AbO-6: C and D; AbO-8: E and F.
 .fected cells Fig. 6, right side panel with Triton
X-100, revealed bright fluorescent staining in cells
expressing the exchanger protein. No fluorescence
was revealed when the primary antibody was omitted
 . not shown or, in mock transfected cells Fig. 6,
.panels A and B . Similar results were also obtained
when Tween 20, Digitonin or Nonidate P-40 were
used to permeabilize the cells. The finding that none
of the antipeptide antibodies detected the exchanger
protein without permeabilization suggests, that their
corresponding epitopes are not accessible from the
extracellular face of the membrane.
3.4. Topological studies of the Naq–Ca2q exchanger
using Flag epitope tagging
In order to obtain more information about the
topology of the Naq–Ca2q exchanger protein, the
method of epitope tagging was used. The Flag-epi-
tope, consisting of eight hydrophilic amino acids, was
introduced into the N-terminus of the protein FN1
.  .and FN2 , the C-terminus FC and into selected
putative extramembraneous loops of RBE-2 see Fig.
.7 . Ten mutants containing the Flag epitope were
 .constructed. Fig. 7 also shows the intracellular in or
 .extracellular out location of the epitopes in the
different topological models. Prior to usage of the
Flag-tagged mutants for studying the topology of the
Naq–Ca2q exchanger protein in the plasma mem-
brane, we had to ensure that introduction of the
epitope did not impair functional conformation. This
was done by measuring Naq–Ca2q exchange activity
in whole HeLa cells transfected with the mutant
exchangers. The transport activity of the mutants was
compared to that of the wild type exchanger RBE-2,
as shown in Table 1. It can be seen, that only four out
of the 10 Flag-tagged mutant exchangers: FN1, FN2,
FE77 and FC, retained the ability to carry out Naq–
Ca2q exchange. Insertion of the epitope into the
 .N-terminal FN1 and FN2 mutants , resulted in about
80% activity as compared to the wild type exchanger
RBE-2. FE77 exhibited about 50% activity and the
FC mutant 140% relative to RBE-2. Expression of
Naq–Ca2q exchange activity in whole cells by these
four Flag-tagged mutant proteins not only indicated
that they retained functional conformation, but also
that they were targeted to the plasma membrane.
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Transfection of HeLa cells with all the other Flag-
tagged mutants did not result in functional expression
in whole cells. To rule out the possibility that these
non-functional Flag mutants were defective in their
protein synthesis, we have determined the amount of
exchanger protein formed. Proteins derived from the
Naq–Ca2q exchanger, were immunoprecipitated with
the site specific antibody AbO-10. Immunodetection
q 2q  . q 2qFig. 7. Construction of the Flag epitope tagged Na –Ca exchanger mutants. A Schematic presentation of the Na –Ca exchanger
based on the hydropathy plot. Numbered boxes represent the 11 TM helices. Dark lines represent the extramembraneous hydrophilic
 .segments. Arrows indicate the sites of the epitope tag insertion. B Oligonucleotides used for mutagenesis. The nucleotide and the
translated amino acid sequences of the Flag tag are presented in italic letters. The sequences flanking the tag are shown for each mutant.
The number preceding the position of the first amino acid of each primer corresponds to its location in the linear sequence of the protein.
The underlined nucleotide sequences indicate the restriction sites that were created and the underlined amino acids are the corresponding
altered amino acids. The following changes in amino acid sequences were done: I“L: FE77 and FK162; V“L: FK807 and FK854.
 .The names of the mutants start with F Flag which is followed by the name of the amino acid at the site of the insertion and its position
 .  .in the exchanger protein, except for the N-terminal FN-Flag in the N-terminal and C-terminal FC-Flag in the C-terminal mutants.
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Table 1
The Naq–Ca2q exchange activity measured in HeLa cells ex-
pressing the Flag-tagged mutants
 .Mutant Activity SD
 .RBE-2 w.t. 100
 .FN1 78 20
 .FN2 93 17







 .FC 139 21
Naq gradient dependent Ca2q uptake was measured in whole
HeLa cells expressing each one of the Flag mutants as described
in Section 2. The exchange activity, is presented relative to that
 .obtained in cells expressing RBE-2. The standard deviation SD
is shown in brackets. The 100% activity corresponds to 6.88
45 2q  .nmoles Ca rmg proteinr10 min. NDsnot detectable .
of the FC-mutant, where the Flag epitope replaced
the last 8 amino acids of the wild type exchanger,
was done with antibody AbO-8. Fig. 8 demonstrates,
that transfection with all the Flag-mutants resulted in
the production of a 130 kDa protein, which fits the
calculated molecular mass of the Naq–Ca2q ex-
changer. Moreover, using AbO-10, which recognizes
the C-terminus of the protein, for immunoprecipita-
tion, also indicates that the synthesis of the protein
proceeded to completion.
To examine whether the non-functional Flag mu-
tants were defective only in targeting to the plasma
membrane, we have solubilized the membranes of the
transfected cells and reconstituted their proteins. Re-
constitution of the non-functional Flag mutants, did
not rescue their transport activities.
Topology studies were done only with the four
mutants that retained Naq–Ca2q exchange activity.
The location of the Flag epitope in these mutant
proteins respective to the plasma membrane was de-
termined by indirect immunofluorescence, in a simi-
lar manner to that done with the anti-peptide antibod-
ies. Intact or permeabilized HeLa cells expressing the
mutants were incubated with the anti-Flag mono-
clonal antibody, and the binding of which was exam-
ined by exposure to FITC conjugated anti-mouse
secondary antibody. The immunofluorescence ob-
tained with intact cells is shown in the left side panel
of Fig. 9 and that obtained in permeabilized cells, is
shown in the right side panel. In panel A, it can be
seen that cells transfected with FN2, the mutant
containing the epitope in the N-terminal tail, stained
around the cell periphery in the absence of permeabi-
 .lization. None of the other mutants FE77 and FC
expressing cells, stained under these conditions pan-
.els C and E . Permeabilization of the cells resulted in
diffuse fluorescent staining in the periphery and within
the cells. These results indicate that the amino termi-
nus of the exchanger protein is extracellular. In con-
trast to FN2, the insertion of the Flag epitope into the
 .N-terminal at G37 mutant FN1 , results in different
staining pattern. FN1 transfected cells stain only in
the presence of a cell permeabilizing agent not
.shown .
Fig. 8. The immunoprecipitation of the epitope-tagged RBE-2 expressed in HeLa cells. Proteins from cells transfected with the
Flag-tagged mutants were precipitated by the anti-peptide antibody AbO-10 except of the FC mutant which was immunoprecipitated by
AbO-8. Cells transfected with the wild-type rbe-2 and mock transfected with pBluescript were used as controls. 1: RBE-2; 2: KS; 3: FC;
4: FE889; 5: FK854; 6: FK807; 7: FE749; 8: FK162; 9: FD130; 10: FE77; 11: FN1; 12: FN2.
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4. Discussion
In this work, we used indirect immunofluorescence
microscopy of cells expressing the Naq–Ca2q ex-
changer RBE-2 or its Flag-epitope tagged mutants, to
study the membrane topology of the protein.
Of the six antipeptide antibodies prepared against
chosen extramembraneous segments, three AbO-6,
.AbO-8 and AbO-10 detected in a specific manner
the exchanger protein. As shown in Fig. 4, the appar-
ent molecular mass of the specific protein band,
which is revealed by the antipeptide antibodies in
transfected cells, is of somewhat higher mobility than
that in native membranes. This can result from either
a different glycosylation pattern in heart, brain and
transfected HeLa cells, or from differences in confor-
mation of the denatured proteins derived from differ-
ent cells. There is also a difference of about 3 kDa
between the exchanger protein identified in rat brain
synaptic membranes and in dog sarcolemma. This fits
Fig. 9. The in situ detection of epitope-tagged RBE-2 by immunofluorescence. HeLa cells expressing the epitope tagged Naq–Ca2q
 .exchanger isoform RBE-2 were treated with the anti-Flag monoclonal antibody diluted 1:300 . The right side panel shows labeling of
cells permeabilized with 0.25% Triton X-100 and the left side panel shows the labeling of non-permeabilized cells. Bound antibodies
 .  .were detected with FITC-conjugated goat anti-mouse antibodies diluted 1:1000 . The epitope tags in constructs FE77 C and D and FC
 .  .E and F were detected only in permeabilized cells, while the tag in FN1 A and B was revealed both in permeabilized and in
non-permeabilized cells.
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the expected difference in molecular mass, based on
the splice variant that is expressed in each one of
w xthese tissues 28 .
To date, three different genes were found to code
q 2q w xfor the mammalian Na –Ca exchanger: NCX1 2 ,
w x w xNCX2 3 and NCX3 4 . NCX1 and probably NCX3
w x29 are alternatively spliced. NCX1 splicing can lead
w xto the expression of over 32 isoforms 31 . In the
brain and in the kidney, multiple isoforms of the
w xNCX1 gene are expressed 28,30 . AbO-8 was raised
against a peptide segment which is present in all
 .three brain rat and rabbit and kidney isoforms.
AbO-6, however, was prepared against a segment
 .that was present in one brain RBE-2 or NaCa5 and
 . w xone kidney NaCa7 isoform 17,28 . In the brain, in
addition to the NCX1 gene, NCX2 and NCX3 are
also expressed. Although these gene products have
about 70% homology to NCX1, they do not exhibit
any sequence, which is homologous to those against
which AbO-6 and AbO-8 were raised. Hence, we
assume that these two antibodies will not be able to
recognize the gene products of NCX2 and NCX3. We
do not know whether AbO-10 will be able to bind to
the exchanger proteins derived from NCX2 or NCX3,
but the sequence homology in the C-terminal of the
three genes suggests that this might be possible.
Based on sequence homology, none of our antibodies
should recognize the NCKX gene products. It is not
known whether each isoform of NCX1 or any other
exchanger genes are expressed in different cells or, if
the different gene products co-localize in the same
cells. No information is available whether their rela-
tive expression pattern changes during development
or in different physiological and pathological condi-
tions. The combined usage of our three antibodies
should provide useful tools to answer these questions.
Immunocytochemical studies with the three an-
tipeptide antibodies AbO-6, AbO-8 and AbO-10 show
that the detection of the fluorescent signal derived
from RBE-2 transfected cells in situ depends on the
presence of detergent. This suggests that the epitopes
to which the antibodies bind are not accessible from
the extracellular face of the membrane. Two of these
 .antipeptide antibodies AbO-6 and AbO-8 , were
raised against protein segments in the large loop see
.Fig. 2 of the exchanger protein. This loop is pre-
dicted to be intracellular by all models that we have
considered. This also fits the identification of amino
w xacids 219–238 2 as a consensus sequence for
calmodulin binding, the presence of a phosphoryla-
w xtion site between amino acids 240–475 12 and the
localization of an internal Ca2q regulatory site, in the
w xamino acid segment 440–510 32 . Taken together
with the intracellular location of amino acids 620–650
as revealed by our immunofluorescence studies see
.Fig. 6 and the binding studies with monoclonal
w xantibodies 13 to cardiomyocyte homogenates and
not to intact cells, the hydrophilic stretch of amino
acids starting at R219 and ending either at S725 Fig.
.  .1A or at N752 Fig. 1B , is intracellular.
 .The studies with AbO-10 Fig. 6, panels G and H
and with cells expressing FC, the epitope tagged
 .C-terminal mutant of RBE-2 Fig. 9 panels E and F
provide experimental evidence, that the carboxy ter-
minal extramembraneous tail of the exchanger is
cytoplasmic. Hence, an even number of TM segments
has to separate the large cytoplasmic loop and the
C-terminal tail of the protein. This requirement fits
 .the hydropathy analysis based model Fig. 1A in
which 6 TM helices separate the large cytoplasmic
loop and the C-terminal tail and the 8 TM helical
 . model the second best of the network system see
.the legend to Fig. 1B , in which 4 TM helices are
identified between N752 and the C-terminal. Our
immunofluorescence studies with the FN2 mutant of
RBE-2 show that the amino terminal of the ex-
changer protein is accessible by the anti-Flag anti-
body without permeabilizing the transfected cells in
 .situ Fig. 9 indicating that the exchanger protein is
an N –C transporter. This fits only the modelout in
 .based on hydropathy analysis Fig. 1A . Moreover,
the extracellular location of the N-terminal also sug-
gests that an uneven number of transmembrane seg-
ments should separate the amino terminal and the
large intracellular loop. We do not know why detec-
tion of fluorescent signal using FN1 tagged RBE-2
expressing cells depended on cell permeabilization. It
is possible that due to the proximity of G37 to the
membrane, or to the glycosylation site at N9, the
epitope is not accessible to the antibody and deter-
gent treatment is needed to reveal it.
Both network system based topological models
 .HTM 8 or HTM 9 see Fig. 1 identify only 4 TM
segments between the amino terminal and the large
cytoplasmic loop. They also predict, that the N-termi-
nal of the protein is intracellular. This prediction does
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not fit the experimental evidence provided by the
FN2 mutant of RBE-2, the presence of the signal
 . w xpeptidase cleavage site between A -1 and D1 9 and
w xthe glycosylation site at N9 10 . This also does not
fit the immunofluorescence studies with FE77 tagged
RBE-2 expressing cells that suggest that the Flag
 .epitope inserted after E77 is intracellular see Fig. 1 .
Combination of the experimental evidence obtained
with FN2, FN1 and FE77 mutants show, that the
amino terminal tail of the protein is extracellular, it is
followed by a hydrophobic stretch of amino acids
identified in the three models as TMS1 and an intra-
cellular hydrophilic loop that connects to TMS2.
Insertion of the Flag epitope into all other loca-
tions except the N- and C-terminals and the ex-
tramembraneous loops connecting TMS1 and TMS2,
impaired functional expression. Hence, these mutants
could not be used to solve inconsistencies among
topological models. Since transfection of the cells
with these mutant exchangers resulted in the synthe-
sis of protein it is possible, that the introduction of
the Flag epitope either impaired the functional con-
formation of the protein or, interrupted a linear seg-
ment, the sequence of which is of importance to
Naq–Ca2q exchange. In an attempt to clarify the
inconsistency between the experimental evidence and
the topological predictions of the network program,
we have submitted for analysis the complete amino
acid sequence derived from the open reading frame
 .of the cloned rbe-2 including the signal peptide .
This, however, resulted in identical topological pre-
dictions to those obtained for the signal peptide trun-
w xcated protein. Fischbarg et al. 33 compared the
predicted structures of several transport proteins and
channels by hydropathy analysis over windows of 21
and 7 amino acids, by the neural network program
 .PHD and by their own program UCFP. They sug-
gest that many inconsistencies originate in the as-
sumption that TMS of membrane proteins are a
helices, when they are in fact organized as anti-
parallel b barrels. If this applies to the structure of
the Naq–Ca2q exchanger as well, it might provide an
explanation for the different topological models.
Acknowledgements
We would like to thank Dr. Burkhard Rost from
the EMBL, Heidelberg, Germany, for carrying out
personally some of the sequence analyses by the
Profile fed neural network systems PHD. This work
has been supported in part by The Bernard Katz
Minerva Center and by research grants obtained from
the U.S.–Israel Binational Science Foundation and
from the Israel Ministry of Health. Orna Cook and
Walter Low were supported in part by the Leo Fromer
Fund.
References
w x1 D.W. Hilgemann, K.D. Philipson, G. Vassor, Ann. NY
 .Acad. Sci. 779 1996 .
w x  .2 D.A. Nicoll, S. Longoni, K.D. Philipson, Science 250 1990
562–565.
w x3 Z. Li, S. Matsuoka, L.V. Hryshko, D.A. Nicoll, M.M.
Bersohn, E.P. Burke, R.P. Lifton, K.D. Philipson, J. Biol.
 .Chem. 269 1994 17434–17439.
w x4 D.A. Nicoll, B.D. Quednau, Z. Qui, Y.R. Xia, A.J. Lusis,
 .K.D. Philipson, J. Biol. Chem. 271 1996 24914–24921.
w x5 H. Reilander, A. Achilles, U. Friedel, G. Maul, F. Lottspe-
 .ich, N.J. Cook, EMBO J. 11 1992 1689–1695.
w x6 D. Dahan, R. Spanier, H. Rahamimoff, J. Biol. Chem. 266
 .1991 2067–2075.
w x7 J. Lytton, K.-H. Rhee, D. Bungard, S.L. Lee, Biophys. J. 70
 .1996 A7, Su-Am-E2.
w x  .8 J. Kyte, R.F. Doolittle, J. Mol. Biol. 157 1982 105–132.
w x9 J.T. Durkin, D.C. Ahrens, Y.C. Pan, J.P. Reeves, Arch.
 .Biochem. Biophys. 290 1991 369–375.
w x10 L.V. Hryshko, D.A. Nicoll, J.N. Weiss, K.D. Philipson,
 .Biochim. Biophys. Acta 1151 1993 35–42.
w x11 D.O. Levitsky, D.A. Nicoll, K.D. Philipson, J. Biol. Chem.
 .269 1994 22847–22852.
w x12 T. Iwamoto, Y. Pan, S. Wakabayashi, T. Imagawa, H.I.
 .Yamanaka, M. Shigekawa, J. Biol. Chem. 271 1996
13609–13615.
w x13 H. Porzig, Z. Li, D.A. Nicoll, K.D. Philipson, Am. J.
 .Physiol. 265 1993 C748–C756.
w x  .14 B. Rost, C. Sander, Proc. Natl. Acad. Sci. USA 90 1993
7558–7562.
w x  .15 B. Rost, C. Sander, J. Mol. Biol. 232 1993 584–599.
w x16 B. Rost, R. Casadio, P. Fariselli, C. Sander, Protein Sci. 4
 .1995 521–533.
w x17 I. Furman, O. Cook, J. Kasir, H. Rahamimoff, FEBS Lett.
 .319 1993 105–109.
w x18 T.A. Kunkel, K. Bebenek, J. McClary, Methods Enzymol.
 .204 1991 125–139.
w x19 F. Sanger, S. Niklen, A.R. Coulson, Proc. Natl. Acad. Sci.
 .74 1977 5463–5467.
w x  .20 W. Low, J. Kasir, H. Rahamimoff, FEBS Lett. 316 1993
63–67.
w x21 R.D. Blakely, J.A. Clark, G. Rudnick, S.G. Amara, Anal.
 .Biochem. 194 1991 302–308.
( )O. Cook et al.rBiochimica et Biophysica Acta 1371 1998 40–5252
w x  .22 A. Barzilai, H. Rahamimoff, Biochemistry 26 1987 6113–
6118.
w x  .23 J.S. Frank, K.D. Philipson, S. Beydler, Circ. Res. 54 1984
414–423.
w x24 K.D. Philipson, R. Ward, Biochim. Biophys. Acta 897
 .1987 152–158.
w x25 E. Harlow, D. Lane, Antibodies: A Laboratory Manual,
Cold Spring Harbor Laboratory, New York, 1988.
w x26 I. Furman, O. Cook, J. Kasir, W. Low, H. Rahamimoff, J.
 .Biol. Chem. 270 1995 19120–19127.
w x  .27 U.K. Laemmli, Nature 227 1970 680–685.
w x  .28 S.L. Lee, A.S. Yu, J. Lytton, J. Biol. Chem. 269 1994
14849–14852.
w x29 B.D. Quednau, D.A. Nicoll, K.D. Philipson, Am. J. Physiol.
 .272 1997 C1250–C1261.
w x30 P. Kofuji, W.J. Lederer, D.H. Schulze, J. Biol. Chem. 269
 .1994 5145–5149.
w x31 N. Gabellini, T. Iwata, E. Carafoli, J. Biol. Chem. 270
 .1995 6917–6924.
w x32 S. Matsuoka, D.A. Nicoll, L.V. Hryshko, D.O. Levitsky,
 .J.N. Weiss, K.D. Philipson, J. Gen. Physiol. 105 1995
403–420.
w x33 J. Fischbarg, M. Cheung, J. Li, P. Iserovich, F. Czegledy, K.
 .Kuang, M. Garner, Mol. Cell. Biochem. 140 1994 147–
162.
